Back to today’s briefing

Story perspectives

Eli Lilly Eyes UK Investment Boost with NHS Drug Price Reforms

3/30/2026

35 3 Full Breakdown

Summary

Story summary

Eli Lilly plans to resume UK investments if the government raises National Health Service (NHS) drug prices and ends a rebate scheme.
Patrik Jonsson, President of Eli Lilly, expressed optimism about reaching an agreement this summer.
The NHS recently increased its cost-effectiveness thresholds for life-extending drugs.
The UK Department of Health supports changes to medicine pricing to improve patient access to new treatments.

1 of 1

Story summary

Eli Lilly plans to resume UK investments if the government raises National Health Service (NHS) drug prices and ends a rebate scheme.
Patrik Jonsson, President of Eli Lilly, expressed optimism about reaching an agreement this summer.
The NHS recently increased its cost-effectiveness thresholds for life-extending drugs.
The UK Department of Health supports changes to medicine pricing to improve patient access to new treatments.